Clinical details,MOH + CMa patients,EMb patients,Healthy controls,p value
"Age, years",46.6 ± 10.3,38.0 ± 14.4,40.8 ± 9.7,0.078
Sex,"3Mc, 14Fd","4 M, 14 F","11 M, 19 F",0.298
"Headache history, years",22.8 ± 8.9,10.8 ± 6.9,N/Ae,< 0.001
"Medication-overuse duration, years",7.3 ± 6.4,,,
Headache location,Headache location,Headache location,Headache location,Headache location
Right; Left; Bilateral,2 (11.8 %); 2 (11.8 %); 13 (76.5 %),2 (11.1 %); 7 (38.9 %); 9 (50 %),N/A; N/A; N/A,N/A; N/A; N/A
VASf,8.4 ± 1.4,8.0 ± 1.4,,0.465
PHQ9,8.7 ± 6.7,2.4 ± 4.8,2.5 ± 2.2,< 0.05h
GAD-7i,2.9 ± 3.9,1.6 ± 3.6,2.6 ± 2.1,0.729
